Mostrando 20 de 437 items

Convalescent Plasma to Treat COVID-19

Tratamientos

Convalescent Plasma to Treat COVID-19

Tema COVID-19

Recent discovery and development of inhibitors targeting coronaviruses

Tratamientos

Recent discovery and development of inhibitors targeting coronaviruses

Tema COVID-19

Drug treatment options for the 2019-new coronavirus (2019- nCoV)

Tratamientos

Drug treatment options for the 2019-new coronavirus (2019- nCoV)

Tema COVID-19

Effective Treatment of Severe COVID-19 Patients with Tocilizumab

Tratamientos

Effective Treatment of Severe COVID-19 Patients with Tocilizumab

Tema COVID-19

The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options

Tratamientos

The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options

Tema COVID-19

The convalescent sera option for containing COVID-19

Tratamientos

The convalescent sera option for containing COVID-19

Tema COVID-19

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Tratamientos

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Tema COVID-19

Of chloroquine and COVID-19

Tratamientos

Of chloroquine and COVID-19

Tema COVID-19

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Tratamientos

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Tema COVID-19

Harnessing the immune system via FcγR function in immune therapy A pathway to next- gen mAbs

Tratamientos

Harnessing the immune system via FcγR function in immune therapy A pathway to next- gen mAbs

Tema COVID-19

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

Tratamientos

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

Tema COVID-19

Reducing mortality from 2019-nCoV host-directed therapies should be an option

Tratamientos

Reducing mortality from 2019-nCoV host-directed therapies should be an option

Tema COVID-19

In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

Tratamientos

In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

Tema COVID-19

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Tratamientos

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Tema COVID-19

Hydroxychloroquine and azithromycin as a treatment of COVID-19

Tratamientos

Hydroxychloroquine and azithromycin as a treatment of COVID-19

Tema COVID-19

Clinical trials on drug repositioning for COVID-19 treatment

Tratamientos

Clinical trials on drug repositioning for COVID-19 treatment

Tema COVID-19

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Tratamientos

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Tema COVID-19

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Tratamientos

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Tema COVID-19

Preparing for a COVID19 pandemic

Medidas preventivas

Preparing for a COVID19 pandemic

Tema COVID-19

Taking the right measures to control COVID-19

Medidas preventivas

Taking the right measures to control COVID-19

Tema COVID-19